Belgium· BE-AMP-SAM331904-00
Cisplatine Teva 0,5 mg/ml
A cisplatin product containing cisplatin, registered in Belgium by Teva Pharma Belgium. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Cisplatin is registered in 16 of 19 countries.
Countries holding a registration under ATC L01XA01 (cisplatin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Cisplatin · ATC L01XA01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Cisplatin
- Manufacturer
- Teva Pharma Belgium
- Country
- Belgium (BE)
- ATC code
- L01XA01
- ATC class
- Cisplatin
- Defined daily dose
- 6.75 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb2859932
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
593 interactions on record for cisplatin.
Graded by severity as the source publishes them — 65 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cisplatin · interactions on record
593 records
- 65 severe
- 252 moderate
- 20 minor
- 256 info
Most severe, free to view
- AmiodaroneC01BD01severe
- DofetilideC01BD04severe
- DronedaroneC01BD07severe
- EtelcalcetideH05BX04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cisplatin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCisplatin EbeweEbewe Pharma Ges.m.b.H. Nfg.KG
- United KingdomCisplatin 100mg/1000ml in Sodium chloride 0.9% infusion bagsSpecial Order
- United StatesCisplatinFresenius Kabi USA, LLC
- SwitzerlandCisplatin Accord
- GermanyCisplatin AccordAccord Healthcare B.V.
- Japanシスプラチン日本化薬
- FranceCISPLATINE ACCORD 1 mg/ml, solution à diluer pour perfusionACCORD HEALTHCARE FRANCE
- SpainCISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Cisplatin Accord, Cisplatin Ebewe
- Bulgaria · Цисплатин Акорд, Цисплатин Ебеве
- Cyprus · Cisplatin Accord Healthcare, Cisplatin Pfizer Hellas
- Czechia · Cisplatin Ebewe
- Germany · Cisplatin Accord, Cisplatin Hikma
- Denmark · Cisplatin "ebewe", Cisplatin Accord
- Estonia · Cisplatin Accord
- Spain · Cisplatino Accord, Cisplatino Hikma
- Finland · Cisplatin Accord, Cisplatin Ebewe
- France · Cisplatine Accord, Cisplatine Hikma
- United Kingdom (Northern Ireland) · Cisplatin, Cisplatin Accord Healthcare
- Greece · Cisplatin Hospira, Oncoplat
- Croatia · Cisplatin Pliva, Cisplatin Pontus
- Hungary · Cisplatin Accord, Cisplatin Sandoz
- Ireland · Cisplatin Accord Healthcare Ireland, Cisplatin Pfizer Healthcare Ireland
- Italy · Cisplatin Teva, Cisplatino Accord Healthcare Italia
- Lithuania · Cisplatin Accord
- Luxembourg · Cisplatine Teva
- Latvia · Cisplatin Accord
- Malta · Cisplatin Accord Healthcare
- Netherlands · Cisplatine Accord, Cisplatine Hikma
- Norway · Cisplatin Accord
- Poland · Cisplatin Ebewe, Cisplatinum Accord
- Portugal · Cisplatina Accord, Cisplatina Hikma
- Romania · Cisplatină Accord
- Sweden · Cisplatin Accord, Cisplatin Ebewe
- Slovenia · Cisplatin Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3d095d99-84b0-4b9e-abc2-6069f1122923 GET /v1/drugs/3d095d99-84b0-4b9e-abc2-6069f1122923?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Cisplatine Teva 0,5 mg/ml",
"name_fr": "Cisplatine Teva 0,5 mg/ml",
"name_nl": "Cisplatine Teva 0,5 mg/ml",
"amp_code": "SAM331904-00",
"strengths": [
"0.5000"
],
"pack_count": 1,
"substances": [
"Cisplatin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Cisplatin",
"authorisation_numbers": [
"BE331904"
]
}See everything about cisplatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.